YOLFTbeta
NIOX Group PLC

NIOX Group PLC

NIOX · LSE · Healthcare / Medical Devices

64.80GBX+0.80 (+1.25%)

Price History

Full chart

Market Stats

Previous Close64.00
Open62.20
Day Range62.20 – 65.00
52-Week Range52.49 – 74.09
Volume176.57K
Market Cap283.66M
P/E (TTM)33.70
Forward P/E25.06
EPS0.02
Dividend Yield2.32%
Beta-0.04
50-Day Avg65.86
200-Day Avg62.84

About

NIOX Group Plc engages in the design, development, and commercialization of medical devices for the diagnosis, monitoring, and management of asthma and COPD worldwide. The company offers NIOX VERO, a non-invasive and point-of-care system that comprises a small portable device, sensors, individual disposable mouthpieces, and breathing handles for the measurement of fractional exhaled nitric oxide (FeNO) level in patients. The company was formerly known as Circassia Group Plc and changed its name to NIOX Group Plc in September 2022. NIOX Group Plc was incorporated in 2006 and is headquartered in Oxford, the United Kingdom.

Company Details

  • SectorHealthcare
  • IndustryMedical Devices
  • CEOMr. Jonathan Charles Emms
  • Employees97
  • HeadquartersMagdalen Centre, Oxford, United Kingdom, OX4 4GA, UK
  • Websitehttps://www.niox.com

Leadership

  • Mr. Jonathan Charles EmmsCEO & Executive Director · b. 1963
  • Ms. Sarah Elizabeth DuncanCFO & Director · b. 1991
  • Ms. Jodie DriverGlobal Director of Human Resources
  • Mr. Tom ScacciaSenior Vice President of Americas & Research Business
  • Ms. Rebecca Mary Clayton-WherityGroup Operating FD & Company Secretary

Financials

Income Statement

Currency: GBP2011-12-312012-12-312013-12-302013-12-312014-12-302014-12-312015-12-302015-12-312016-12-302016-12-312017-12-302017-12-312018-12-302018-12-312019-12-302019-12-312020-12-302020-12-312021-12-302021-12-312022-12-302022-12-312023-12-302023-12-312024-12-312025-12-31
Total Revenue------10.80M10.80M23.10M23.10M46.30M46.30M48.30M48.30M34.60M34.60M23.90M23.90M27.90M27.90M31.30M31.30M36.80M36.80M41.80M48.70M
Growth (%)-------0.00%+113.89%0.00%+100.43%0.00%+4.32%0.00%-28.36%0.00%-30.92%0.00%+16.74%0.00%+12.19%0.00%+17.57%0.00%+13.59%+16.51%
Cost of Revenue------4.30M4.30M8.00M8.00M10.00M10.00M8.90M8.90M9.10M9.10M7.60M7.60M8.90M8.90M9.10M9.10M10.30M10.30M11.60M19.10M
Gross Profit------6.50M6.50M15.10M15.10M36.30M36.30M39.40M39.40M25.50M25.50M16.30M16.30M19.00M19.00M22.20M22.20M26.50M26.50M30.20M29.60M
Gross Margin------60.19%60.19%65.37%65.37%78.40%78.40%81.57%81.57%73.70%73.70%68.20%68.20%68.10%68.10%70.93%70.93%72.01%72.01%72.25%60.78%
Operating Expense------72.90M72.90M58.90M58.90M118.50M118.50M79.80M79.80M89.30M89.30M33.60M33.60M23.30M23.30M20.40M20.40M21.90M21.90M22.50M18.90M
Operating Income-15.35M-19.14M-24.80M-24.80M-45.80M-45.80M-66.40M-66.40M-43.80M-43.80M-82.20M-82.20M-40.40M-40.40M-63.80M-63.80M-17.30M-17.30M-4.30M-4.30M1.80M1.80M4.60M4.60M7.70M10.70M
Operating Margin-------614.81%-614.81%-189.61%-189.61%-177.54%-177.54%-83.64%-83.64%-184.39%-184.39%-72.38%-72.38%-15.41%-15.41%5.75%5.75%12.50%12.50%18.42%21.97%
EBITDA-15.22M-18.40M877.00K877.00K-45.78M-45.78M-64.60M-64.60M-33.50M-33.50M-66.60M-66.60M-39.50M-39.50M-12.30M-12.30M-9.10M-9.10M3.10M3.10M15.20M15.20M8.60M8.60M12.20M14.80M
EBITDA Margin-------598.15%-598.15%-145.02%-145.02%-143.84%-143.84%-81.78%-81.78%-35.55%-35.55%-38.08%-38.08%11.11%11.11%48.56%48.56%23.37%23.37%29.19%30.39%
Net Income-14.51M-15.50M-19.98M-19.98M-35.10M-35.10M-49.90M-49.90M-137.30M-137.30M-99.10M-99.10M-117.10M-117.10M-48.30M-48.30M-33.50M-33.50M3.60M3.60M16.10M16.10M10.70M10.70M3.70M7.00M
Net Income Margin-------462.04%-462.04%-594.37%-594.37%-214.04%-214.04%-242.44%-242.44%-139.60%-139.60%-140.17%-140.17%12.90%12.90%51.44%51.44%29.08%29.08%8.85%14.37%
R&D13.20M16.49M21.10M21.10M38.60M38.60M46.80M46.80M17.30M17.30M58.40M58.40M10.80M10.80M51.10M51.10M6.80M6.80M4.60M4.60M3.20M3.20M2.30M2.30M2.50M2.60M
R&D as % of Total Revenue------433.33%433.33%74.89%74.89%126.13%126.13%22.36%22.36%147.69%147.69%28.45%28.45%16.49%16.49%10.22%10.22%6.25%6.25%5.98%5.34%
Interest Expense11.00K35.00K------100.00K100.00K100.00K100.00K11.90M11.90M300.00K300.00K300.00K300.00K300.00K300.00K100.00K100.00K200.00K200.00K200.00K200.00K
Interest Expense % of Total Revenue--------0.43%0.43%0.22%0.22%24.64%24.64%0.87%0.87%1.26%1.26%1.08%1.08%0.32%0.32%0.54%0.54%0.48%0.41%

Balance Sheet

Currency: GBP2011-12-312012-12-312013-12-302013-12-312014-12-302014-12-312015-12-302015-12-312016-12-302016-12-312017-12-302017-12-312018-12-302018-12-312019-12-302019-12-312020-12-302020-12-312021-12-302021-12-312022-12-302022-12-312023-12-302023-12-312024-12-312025-12-31
Total Assets--38.03M38.03M200.50M200.50M489.20M489.20M334.10M334.10M402.40M402.40M307.40M307.40M246.80M246.80M103.10M103.10M86.40M86.40M98.50M98.50M91.50M91.50M68.40M76.20M
Total Liabilities--7.99M7.99M9.70M9.70M48.30M48.30M21.50M21.50M30.80M30.80M124.40M124.40M162.00M162.00M37.00M37.00M19.60M19.60M16.60M16.60M7.70M7.70M8.90M8.60M
Total Equity--30.05M30.05M190.80M190.80M408.50M408.50M280.70M280.70M224.80M224.80M125.90M125.90M84.80M84.80M66.10M66.10M66.80M66.80M81.90M81.90M83.80M83.80M59.50M73.70M
Cash--23.57M23.57M29.70M29.70M166.00M166.00M97.40M97.40M44.50M44.50M40.70M40.70M27.00M27.00M7.40M7.40M12.60M12.60M19.40M19.40M19.90M19.90M10.90M19.90M
Total Debt--2.01M2.01M----------111.40M111.40M1.60M1.60M1.30M1.30M1.00M1.00M1.10M1.10M1.50M1.00M
Net Debt---21.56M-21.56M-29.70M-29.70M-166.00M-166.00M-97.40M-97.40M-44.50M-44.50M-40.70M-40.70M84.40M84.40M-5.80M-5.80M-11.30M-11.30M-18.40M-18.40M-18.80M-18.80M-9.40M-18.90M

Cash Flow

Currency: GBP2013-12-302013-12-312014-12-302014-12-312015-12-302015-12-312016-12-302016-12-312017-12-302017-12-312018-12-302018-12-312019-12-302019-12-312020-12-302020-12-312021-12-302021-12-312022-12-302022-12-312023-12-302023-12-312024-12-312025-12-31
Operating Cash Flow-17.88M-17.88M-36.90M-36.90M-55.80M-55.80M-56.70M-56.70M-57.60M-57.60M-40.60M-40.60M-25.10M-25.10M-23.90M-23.90M1.40M1.40M6.70M6.70M11.60M11.60M17.20M15.80M
Investing Cash Flow27.18M27.18M-149.90M-149.90M-67.10M-67.10M-12.40M-12.40M5.20M5.20M15.60M15.60M-9.90M-9.90M-500.00K-500.00K-200.00K-200.00K-100.00K-100.00K-300.00K-300.00K-1.00M-1.20M
Financing Cash Flow2.00K2.00K192.50M192.50M258.60M258.60M-3.60M-3.60M-1.60M-1.60M20.30M20.30M21.90M21.90M4.30M4.30M4.10M4.10M-500.00K-500.00K-10.50M-10.50M-25.10M-5.50M
Capital Expenditure00300.00K300.00K200.00K200.00K700.00K700.00K800.00K800.00K100.00K100.00K300.00K300.00K500.00K500.00K200.00K200.00K100.00K100.00K300.00K300.00K1.00M200.00K
Free Cash Flow-17.88M-17.88M-37.20M-37.20M-56.00M-56.00M-57.40M-57.40M-58.40M-58.40M-40.70M-40.70M-25.40M-25.40M-24.40M-24.40M1.20M1.20M6.60M6.60M11.30M11.30M16.20M15.60M
Dividends Paid--------------------10.50M10.50M4.20M5.00M
FCF to OCF100.00%100.00%100.81%100.81%100.36%100.36%101.23%101.23%101.39%101.39%100.25%100.25%101.20%101.20%102.09%102.09%85.71%85.71%98.51%98.51%97.41%97.41%94.19%98.73%
Dividend Paid to FCF--------------------92.92%92.92%25.93%32.05%

Earnings

Report DateMar 11, 2016Sep 27, 2016Apr 25, 2017Sep 27, 2017Apr 24, 2018Sep 27, 2018May 1, 2019Sep 26, 2019Jun 16, 2020Sep 17, 2020Jun 14, 2021Sep 16, 2021Mar 22, 2022Sep 14, 2022Mar 21, 2023Sep 24, 2024Apr 1, 2025Sep 30, 2025Oct 2, 2025Sep 29, 2026Mar 23, 2027
EPS Estimate0.000.000.000.000.000.000.000.000.000.000.000.000.000.00-0.000.000.000.00--
EPS Actual-0.09-0.05-0.08-0.10-0.19-0.08-0.07-0.08-0.05-0.03-0.040.000.010.020.010.010.010.010.01--
Surprise---------------------
TimingPre-marketPre-marketPre-marketAfter-hoursPre-marketPre-marketPre-marketPre-marketPre-marketPre-market-Pre-marketPre-marketPre-marketPre-market----After-hoursAfter-hours

Key Statistics & Ratios

Market Cap283.66M
Enterprise Value265.61M
Trailing P/E33.70
Forward P/E25.06
Price / Sales5.97
Price / Book4.21
EPS0.02
Book Value0.162
Revenue (TTM)47.50M
Gross Profit (TTM)33.00M
EBITDA14.20M
Profit Margin14.74%
Operating Margin22.92%
Return on Equity10.73%
Return on Assets9.02%
Shares Outstanding420.87M
Shares Float330.28M
Beta-0.04
Dividend Yield2.32%
Dividend Rate0.02
Payout Ratio111.51%

Dividends

20261×
0.02May 21, 2026
20251×
0.01May 15, 2025
20241×
0.01May 23, 2024
20231×
0.03Aug 17, 2023